Otros idiomas Emmaus Life Sciences, Inc.

Acciones

EMMA

US29137T1016

Mercado cerrado - OTC Markets Otros sitios de cotización 16:04:40 28/06/2024			Varia. Cinco días.	Varia. 1 de enero.
0,1012 ^USD	+11,15 %		+11,21 %	+1,10 %

02/02	Emmaus Life Sciences, Inc. Recibe la autorización de comercialización del Departamento de Salud de Puerto Rico para Endari® (L-glutamina polvo oral)	CI
2023	Emaús Life Sciences, Inc. informa de los resultados del tercer trimestre y de los nueve meses finalizados el 30 de septiembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Emmaus Life Sciences : Certificate of Incorporation/Bylaws - Form 8-K	28/05
Emmaus Life Sciences Reports Delayed Filing of Annual Report	15/04
Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico	02/02
Emmaus Life Sciences, Inc. Receives Marketing Authorization from the Puerto Rico Department of Health for Endari® (L-Glutamine Oral Powder)	02/02
Emmaus Life Sciences : Material Agreement - Form 8-K	20/12
Earnings Flash (EMMA) EMMAUS LIFE SCIENCES Posts Q3 Revenue $5M	14/11
Emmaus Life Sciences Reports Q3 2023 Financial Results	14/11
Emmaus Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Emmaus Life Sciences, Inc. Announces Board Changes	04/10/23
Emmaus Life Sciences Reports Management Changes	23/08/23
Emmaus Life Sciences, Inc. Announces Yutaka Niihara No Longer Serve as Chief Executive Officer	23/08/23
Emmaus Life Sciences, Inc. Announces Management Changes	23/08/23
Emmaus Life Sciences Reports Q2 2023 Financial Results	14/08/23
Emmaus Life Sciences : Reports Q2 2023 Financial Results - Form 8-K	14/08/23
Emmaus Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman	13/07/23
Emmaus Life Sciences, Inc Receives Marketing Authorization for EndariÂ® in Oman	13/07/23
Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA	31/05/23
Emmaus Life Sciences, Inc. Receives Medicine Registration Certificate from the Bahrain National Health Regulatory Authority	31/05/23
Emmaus Life Sciences, Inc. Receives Medicine Registration Certificate from the Bahrain National Health Regulatory Authority	31/05/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Emmaus Life Sciences, Inc.

Acciones

EMMA

US29137T1016

Otros idiomas

Filtros